Literature DB >> 20540707

Cosalane and its analogues: a unique class of anti-HIV agents.

Peng Zhan1, Zhenyu Li, Xinyong Liu.   

Abstract

Cosalane and related compounds are a peculiar group of anti-HIV agents with activities against a broad range of viral targets, such as viral entry and reverse transcriptase (RT). Cosalane and its analogues having anionic pharmacophore inhibit the binding of gp120 to CD4 as well as the fusion of the viral envelope with the cell membrane. The alkenyldiarylmethanes (ADAMs), characterized by the lack of the steroidal moiety of cosalane, are a unique class of non-nucleoside reverse transcriptase inhibitors (NNRTIs) that have potential value in the treatment of HIV infection. In this article, the structural modifications, structure-activity relationship (SAR) studies and/or crystallographic studies of cosalane related derivatives as potent antiviral agents were reviewed, which will be beneficial to the discovery of next generation cosalane derivatives with improved antiviral potency, metabolic stability and bioavailability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540707     DOI: 10.2174/138955710792007222

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  3 in total

1.  Positive reinforcement for viruses.

Authors:  Frederic Vigant; Michael Jung; Benhur Lee
Journal:  Chem Biol       Date:  2010-10-29

2.  Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure.

Authors:  Jon Ander Nieto-Garai; Bärbel Glass; Carmen Bunn; Matthias Giese; Gary Jennings; Beate Brankatschk; Sameer Agarwal; Kathleen Börner; F Xabier Contreras; Hans-Joachim Knölker; Claudia Zankl; Kai Simons; Cornelia Schroeder; Maier Lorizate; Hans-Georg Kräusslich
Journal:  Front Immunol       Date:  2018-09-04       Impact factor: 7.561

Review 3.  Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.

Authors:  Lucianna Helene Santos; Rafaela Salgado Ferreira; Ernesto Raúl Caffarena
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-11       Impact factor: 2.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.